ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What’s in Store?
ZacksANI Pharmaceuticals’ (ANIP) revenues in the first quarter of 2024 are likely to have been driven by increased sales of its lead product, Cortrophin Gel, as well as growth in its generics business.